Knockout of the Cardiac Transcription Factor NKX2-5 Results in Stem Cell-Derived Cardiac Cells with Typical Purkinje Cell-like Signal Transduction and Extracellular Matrix Formation.
CrispR-Cas9
NKX2-5
cardiac conduction system
collagen
connexin
hiPSC
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Aug 2023
29 Aug 2023
Historique:
received:
31
07
2023
revised:
16
08
2023
accepted:
27
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
The human heart controls blood flow, and therewith enables the adequate supply of oxygen and nutrients to the body. The correct function of the heart is coordinated by the interplay of different cardiac cell types. Thereby, one can distinguish between cells of the working myocardium, the pace-making cells in the sinoatrial node (SAN) and the conduction system cells in the AV-node, the His-bundle or the Purkinje fibres. Tissue-engineering approaches aim to generate hiPSC-derived cardiac tissues for disease modelling and therapeutic usage with a significant improvement in the differentiation quality of myocardium and pace-making cells. The differentiation of cells with cardiac conduction system properties is still challenging, and the produced cell mass and quality is poor. Here, we describe the generation of cardiac cells with properties of the cardiac conduction system, called conduction system-like cells (CSLC). As a primary approach, we introduced a CrispR-Cas9-directed knockout of the NKX2-5 gene in hiPSC. NKX2-5-deficient hiPSC showed altered connexin expression patterns characteristic for the cardiac conduction system with strong connexin 40 and connexin 43 expression and suppressed connexin 45 expression. Application of differentiation protocols for ventricular- or SAN-like cells could not reverse this connexin expression pattern, indicating a stable regulation by NKX2-5 on connexin expression. The contraction behaviour of the hiPSC-derived CSLCs was compared to hiPSC-derived ventricular- and SAN-like cells. We found that the contraction speed of CSLCs resembled the expected contraction rate of human conduction system cells. Overall contraction was reduced in differentiated cells derived from NKX2-5 knockout hiPSC. Comparative transcriptomic data suggest a specification of the cardiac subtype of CSLC that is distinctly different from ventricular or pacemaker-like cells with reduced myocardial gene expression and enhanced extracellular matrix formation for improved electrical insulation. In summary, knockout of NKX2-5 in hiPSC leads to enhanced differentiation of cells with cardiac conduction system features, including connexin expression and contraction behaviour.
Identifiants
pubmed: 37686171
pii: ijms241713366
doi: 10.3390/ijms241713366
pmc: PMC10487652
pii:
doi:
Substances chimiques
Homeobox Protein Nkx-2.5
0
NKX2-5 protein, human
0
Transcription Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : Se1077/13-1
Organisme : Deutsche Forschungsgemeinschaft
ID : FOR 5146
Organisme : Deutsche Forschungsgemeinschaft
ID : GRK 2515
Références
Intern Med. 2022 Jul 15;61(14):2161-2165
pubmed: 35283377
Dev Dyn. 1995 Dec;204(4):358-71
pubmed: 8601030
Pharmacol Ther. 2005 Aug;107(2):252-68
pubmed: 15925411
Genome Biol. 2014;15(12):550
pubmed: 25516281
Circ Res. 2006 Jun 23;98(12):1555-63
pubmed: 16709898
Cardiovasc Res. 2008 Oct 1;80(1):9-19
pubmed: 18519446
Circ Res. 2010 Feb 19;106(3):434-46
pubmed: 20167941
Stem Cells. 2020 Mar;38(3):352-368
pubmed: 31648393
Cardiovasc Res. 2011 Mar 1;89(4):744-53
pubmed: 20962103
Curr Protoc Stem Cell Biol. 2017 Feb 2;40:1F.16.1-1F.16.13
pubmed: 28152183
J Mol Cell Cardiol. 2022 May;166:1-10
pubmed: 35081367
PLoS One. 2016 Oct 7;11(10):e0164093
pubmed: 27716829
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Cardiovasc Res. 2001 Oct;52(1):40-50
pubmed: 11557232
Stem Cell Res Ther. 2020 Feb 21;11(1):73
pubmed: 32085809
Circ Res. 2003 May 30;92(10):1079-88
pubmed: 12775656
Stem Cell Reports. 2015 Jun 9;4(6):1089-102
pubmed: 26028533
Can J Cardiol. 2010 Aug-Sep;26 Suppl C:8C-13C
pubmed: 20847985
Sci Rep. 2020 Oct 8;10(1):16804
pubmed: 33033381
Circ Res. 2008 Oct 24;103(9):1001-8
pubmed: 18599871
Circulation. 2011 Mar 1;123(8):904-15
pubmed: 21357845
Stem Cell Res. 2022 Jul;62:102811
pubmed: 35679758
Cell Commun Adhes. 2001;8(4-6):339-43
pubmed: 12064615
Milbank Q. 2008 Jun;86(2):273-326
pubmed: 18522614
PLoS One. 2017 May 11;12(5):e0173222
pubmed: 28493867
Stem Cells. 2015 May;33(5):1456-69
pubmed: 25639979
J Muscle Res Cell Motil. 2007;28(2-3):115-21
pubmed: 17572852
Heart Rhythm. 2022 Sep;19(9):1484-1490
pubmed: 35562056
Front Pharmacol. 2013 Jun 27;4:81
pubmed: 23818881
Stem Cell Res. 2022 Jul;62:102793
pubmed: 35500377
Stem Cell Res Ther. 2017 Oct 16;8(1):229
pubmed: 29037217
Stem Cells. 2015 Apr;33(4):1102-12
pubmed: 25524238
Development. 2015 Jul 15;142(14):2521-32
pubmed: 26138475
Cardiovasc Res. 2012 Sep 1;95(4):469-79
pubmed: 22739121
Cell Mol Life Sci. 2022 Jul 21;79(8):440
pubmed: 35864219
NPJ Regen Med. 2017 Apr 7;2:9
pubmed: 29302345
Development. 2014 Aug;141(15):2959-71
pubmed: 25053429